Innovation Practices in Biopharma, MedTech, and Digital Medicine

Abstract

Section two applies the principles presented and summarized in Section One to the production side of the healthcare industry, and consists of 7 chapters (or contributed articles). Our focus is on biopharma (the converged pharma and biotech segments), MedTech, and digital medicine. We also include a discussion on areas of convergence of technology, healthcare, and biopharma as the broader industry has begun adoption of a customer-centric business model that incorporates solutions that merge drugs, devices, and digital technology to impact the entire healthcare system.